Treating long COVID: Clinician experience with post-acute COVID-19 care (webinar)

Mary MadisonTrainingLeave a Comment

Here’s a webinar that may be of interest to you. Free Continuing Education (CE) will be offered for this COCA Call (see beneath Accreditation Statement).

Treating Long COVID: Clinician Experience with Post-Acute COVID-19 Care

Overview

For some people, the effects of COVID-19 can last well beyond the immediate illness. Patients and clinicians across the United States are reporting long-term effects of COVID-19, commonly referred to as long COVID. Symptoms may include cognitive difficulties, fatigue, and shortness of breath. In some patients, critical illness from COVID-19 may be the cause of persistent symptoms, but many patients with long-term effects had mild or asymptomatic acute COVID-19 infection. During this COCA Call, presenters will share their firsthand experiences with treating long COVID, focusing on the pulmonary, neurologic, and psychological aspects. They will also describe their experiences with establishing clinics that provide care for patients with these long-term effects.

If you are unable to attend the live COCA Call, the recording will be available for viewing on the COCA Call webpage a few hours after the live event ends.

The slide set will be available on the day of the call under “Call Materials” on the COCA Call webpage

Free Continuing Education (CE) will be offered for this COCA Call. 

Advanced registration is not required.


Date: Thursday, January 28, 2021

A few minutes before the webinar starts, please click on the Zoom link below to join:
https://www.zoomgov.com/j/
1606808037?pwd=NUx3a1hQd2tV
WVZBU0JobFgxUDJ2Zz09

Passcode: 594536
Or Telephone:
US: +1 669 254 5252 or +1 646 828 7666 or +1 669 216 1590 or +1 551 285 1373

Or iPhone one-tap: 
US:+16692545252,,1606808037#,,,,,,0#,,594536#

or +16468287666,,1606808037#,,,,,,0#,,594536#Webinar ID: 160 680 8037

International numbers available: https://www.zoomgov.com/u/
adQOV17URb

Activity-specific Objectives

At the conclusion of the session, the participant will be able to accomplish the following—

  1. Identify signs and symptoms of long COVID which occur after the acute phase of SARS-CoV-2 infection.
  2. Identify potential multidisciplinary teams for patient care.
  3. Describe common challenges to post-acute COVID-19 care.
  4. Describe examples of patient-centered, interdisciplinary post-acute COVID-19 care.
COCA Call Objectives

At the conclusion of the session, the participant will be able to accomplish the following—

  1. Cite background information on the topic covered during the presentation.
  2. Discuss CDC’s role in the topic covered during the presentation.
  3. Describe the topic’s implications for clinicians.
  4. Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.

Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of health care providers.

Presenters

Alfonso C Hernandez-Romieu, MD, MPH
LCDR, U.S. Public Health Service
Sequelae Unit, Clinical Team
COVID-19 Response
Centers for Disease Control and Prevention

Jennifer Possick, MD
Associate Professor, Section of Pulmonary, Critical Care and Sleep Medicine
Department of Internal Medicine
Yale University School of Medicine

Allison Navis, MD
Assistant Professor, Division Neuro-Infectious Diseases
Icahn School of Medicine at Mount Sinai
Mount Sinai Health System

Instructions for Obtaining Continuing Education 

To receive continuing education (CE) for WC2922-012821 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Treating Long COVID: Clinician Experience with Post-Acute COVID-19 Care, Thursday, January 28, 2021 please visit TCEO and follow these 9 Simple Steps by Monday, March 1, 2021.

To receive continuing education (CE) for WD2922-012821 (Web on Demand)– Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Treating Long COVID: Clinician Experience with Post-Acute COVID-19 Care, Thursday, January 28, 2021, please visit TCEO and follow these 9 Simple Steps by Thursday, March 2, 2023.

Accreditation Statement

CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity provides 1.0 contact hour.

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.

CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive) 0.1 CEUs in pharmacy education.

The Universal Activity Number is JA4008229-0000-21-014-L04-P and enduring JA4008229-0000-21-015-H04-P course category.

This activity has been designated as Knowledge-Based.

Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

For Certified Public Health Professionals (CPH)

The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1.0 CPH recertification credit for this program.

AAVSB/RACE: This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession. DISCLOSURE: In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias. The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use. CDC did not accept commercial support for this continuing education activity.

The Emergency Risk Communication Branch in the Division of Emergency Operations, Center for Preparedness and Response is responsible for the management of all COCA products.

For information about this update or other clinical issues, or to send your feedback, please contact us at coca@cdc.gov

Health Alert Network—CDC’s primary method of sharing cleared information about urgent public health incidents with public information officers; federal, state, territorial, and local public health practitioners; clinicians; and public health laboratories

CDC and HHS logos are the exclusive property of the Department of Health and Human Services and may not be used for any purpose without prior express written permission. Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services

Links to non-federal organizations are provided solely as a service to our users. Links do not constitute an endorsement of any organization by CDC or the federal government, and none should be inferred. CDC is not responsible for the content of the individual organizations.

Centers for Disease Control and Prevention
1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348

Leave a Reply

Your email address will not be published. Required fields are marked *